Take home message Targeting poison exons can restore protein abundance and ameliorate the outcomes of genetic disorders ...
Planetary Health Festival | Biotechnology Pathways
October 3-4-5 – The Italian Festival of Planetary Health The Planetary Health Festival was created to raise awaren...
Next-generation psychedelics: should new agents skip the trip?
Background Depression affects around 280 million worldwide and one of the major unmet needs is the limited efficacy of t...
Echoes of hope: DB-OTO gene therapy pioneers genetic hearing loss treatment DB-OTO Gene therapy: advancing treatment for genetic hearing loss
Regeneron Pharmaceuticals’ gene therapy, DB-OTO, has shown promising initial results in improving hearing for chil...
The Future of Weight Loss: What Will Be Next After Wegovy?
The next generation of weight loss treatments promises to be more effective, convenient, and accessible, building on the...
BionIT Labs closes a €5.5 million investment round with CDP Venture Capital Sgr, RIF Srl, Sefea Impact Sgr, SIMEST SpA, and Fondazione ENEA Tech e Biomedical
Investment goal: to make the Adam’s Hand bionic prosthesis the premier product in the American prosthetic market and t...